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What does it take to make a regulatory T (Treg) cell? In this issue of Immunity, Ohkura et al. show that Treg-
cell-specific CpG hypomethylation and Foxp3 expression are independent events required for Treg cell
development, stability, and full suppressive activity.Regulatory T (Treg) cells are a small pop-
ulation of CD4+ T cells endowed with
potent suppressive activity (Sakaguchi,
2011; Vignali et al., 2008). They are essen-
tial for the maintenance of immune
homeostasis and for the prevention of
inflammatory and autoimmune disease.
Humans and mice that lack a critical fork-
head or winged-helix family transcription
factor, Foxp3, develop widespread spon-
taneous autoimmunity as a result of the
lack of functional Treg cells. So called
‘‘natural’’ Treg (nTreg) cells develop in
the thymus and constitute the majority of
the peripheral Treg cell pool. In contrast,
induced Treg (iTreg) cells arise predomi-
nately at sites of inflammation and envi-
ronmental interfaces, such as the gut,
but can also be generated in vitro after
T-cell-receptor (TCR) stimulation of con-
ventional CD4+ T cells in the presence of
transforming growth factor-b (TGFb) and
interleukin-2 (IL-2). Both Treg cell popula-
tions require Foxp3 for their development
and function, leading to the notion that
Foxp3 is a ‘‘master regulator’’ of their
development and function and is a domi-
nant component of their etiology (Josefo-
wicz et al., 2012; Ziegler and Buckner,
2009). However, this iconic image of
Foxp3 has come under increasing scru-
tiny; several studies have suggested that
Foxp3 alone might not be sufficient for
the induction of a robust Treg cell
program and maintenance of their
stability. For example, it has been shown
that Treg cell signature genes can be
expressed in the absence of functional
Foxp3 (Gavin et al., 2007; Hill et al.,
2007). These findings indicate that other
molecular mechanisms distinct from
Foxp3 expression must be engaged so
that a Treg-cell-lineage identity crisis
can be avoided. However, the identity of
these additional signals or factors has
remained obscure.In this issue of Immunity, Ohkura et al.
(2012) seek to determine the factors and
epigenetic changes required for Treg cell
fate determination and functional stability.
By examining the DNA CpG methylation
status of Treg-cell-associated genes in
conventional, nTreg, and iTreg cells, they
found that Foxp3 expression alone is not
sufficient to confer Treg-cell-lineage fate,
even in the thymus. Utilizing several trans-
genic mouse lines, they elegantly dis-
sected the roles of Foxp3, TCR signaling,
and other requirements in establishing the
Treg-cell-specific DNA methylation land-
scape, lineage commitment, and mainte-
nance of suppressive function. Indeed,
Treg-cell-lineage determination was es-
tablished by a combination of CpG
hypomethylation of Treg cell signature
genes, as well as the stable expression
of Foxp3. Surprisingly, both events
appeared to occur independently and
required TCR stimulation. The strength
and duration of early TCR signaling in
the thymus also appeared to dictate
stable Treg-cell-lineage commitment.
However, continuous recognition of self-
pMHC is necessary for maintaining the
Treg cell lineage in the periphery.
First, Ohkura et al. used MeDIP-Seq
(methylated DNA immunoprecipitation
followed by deep sequencing) to identify
the DNA methylation pattern of several
Treg cell signature genes, cytokines, and
lineage-specific transcription factors and
thus described a global pattern of deme-
thylation utilized by Treg cells. Bisulfite
sequencing confirmed the heavily deme-
thylated status of several genes identified
from their MeDIP-Seq data set. This
allowed them to generate a Treg cell de-
methylation signature, which they termed
‘‘nTreg-Me,’’ consisting of four key genes:
Foxp3, Tnfrsf18 (encoding GITR), Ctla4,
and Ikzf4 (encoding Eos) (Figure 1). Next,
they assessed whether Foxp3 is requiredImmunity 37, Nfor establishing nTreg-Me. Utilizing
DEREG mice (a bacterial-artificial-chro-
mosome transgenic line that reports
Foxp3 promoter activity with green fluo-
rescent protein [GFP]) crossed to Scurfy
(Foxp3-deficient) mice, nTreg-Me was
examined in mice that lacked Foxp3 but
that reported its activity. Surprisingly, an
nTreg cell demethylation pattern was
established despite the absence of
Foxp3, suggesting that additional, inde-
pendent signals are required for inducing
nTreg-Me.
The authors then utilized several
reporter constructs containing various
combinations of artificially methylated
regions of the Foxp3 promoter or gene
body to assess how nTreg-Me might
regulate gene expression. They found
that DNA methylation both at the pro-
moter and within the gene was respon-
sible for reduced transcriptional activity.
Enforcing global demethylation by knock-
down of DNA methyltransferase I (Dnmt1)
was sufficient to induce Foxp3 expres-
sion, whereas fusing nTreg cells with hy-
permethylated thymoma cells caused
loss of Foxp3 expression and nTreg-Me.
These observations further confirm that
nTreg-specific hypomethylation is critical
for nTreg identity and stability.
Okhura et al. next utilized T cells that
had different combinations of nTreg-Me
and Foxp3 expression to conduct gene-
expression profiling and to assess com-
plementarity (Foxp3 cells transduced
with Foxp3 [nTreg-MeFoxp3+], DEREG-
Scurfy GFP+ cells [nTreg-Me+Foxp3], or
DEREG-Scurfy GFP+ cells transduced
with Foxp3 [nTreg-Me+Foxp3+]). Surpris-
ingly, they showed that the regulation of
gene expression was far more dependent
on the methylation status of Treg-cell-
associated genes than on Foxp3 expres-
sion. Instead, Foxp3 seemed to play
amajor role in repressing the transcriptionovember 16, 2012 ª2012 Elsevier Inc. 759
Figure 1. TCR-Induced CpG Hypomethylation of Treg Cell Signature Genes Facilitates Treg
Cell Development and Stability
Treg cells lacking nTreg-Me (methylation is depicted with white triangles) are more plastic and display
decreased suppressive function and potential loss of Foxp3 expression. Strong TCR signals in the thymus
or continuous TCR signals in the periphery can induce nTreg-Me in several Treg cell signature genes,
although there might be additional signals that further influence the development of the nTreg-Me pheno-
type in T cells.
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Previewsof genes, such as Il2, Ifng, and Zap70, that
might otherwise disrupt the Treg cell
program.
In an elegant experiment, the authors
next assessed the role of nTreg-Me in
Treg-cell-lineage stability. They utilized
DEREG:Foxp3-IRES-Cre:ROSA26-LSL-
RFP triple reporter mice that mark cells
that fully express stable Foxp3 (GFP+
RFP+) or that have recently activated the
Foxp3 locus (GFP+RFP). Interestingly,
only those cells that had fully expressed
Foxp3 long enough to activate the ROSA
locus showed complete nTreg-Me. In
contrast, in vitro stimulation of the
‘‘recently activated’’ GFP+RFP cells re-
sulted in both full Treg cell commitment
(induction of RFP and full nTreg-Me) and
the loss of GFP and nTreg-Me. This
implies that cells expressing Foxp3 for
a short period of time without full nTreg-
Me can lose stability and become plastic.
The authors next investigated the
potential mechanisms that regulate
nTreg-Me. Using TCR transgenic mice,
the authors observed significant upregu-
lation of nTreg-Me in thymocytes stimu-
lated via expression of cognate peptide,
suggesting that strong thymic TCR
stimulation might induce demethylation.
Using in-vivo-generated iTreg cells from760 Immunity 37, November 16, 2012 ª2012an experimental colitis model, they also
showed that nTreg-Me can be induced
by continuous TCR stimulation. Indeed,
in Foxp3/ DEREG reporter mice, cells
possessing self-reactive TCRs had higher
levels of nTreg-Me than did those pos-
sessing non-self-reactive TCRs. Finally,
they showed that nTreg-Me can even be
induced in naive Tconv cells by chronic
TCR stimulation in vitro over the course
of several weeks (with the use of Bcl2
transgenic mice as the T cell source for
maintaining viability). All in all, Ohkura
et al. showed that Foxp3 is not the sole
inducer or regulator of nTreg cell identity.
Whereas Foxp3 is essential for Treg cell
development and function, epigenetic
modifications in the form of hypomethyla-
tion of nTreg signature genes are a crucial
component of the Treg identity and,
surprisingly, do not require Foxp3.
The issue of Treg stability has been
a hot topic as of late. Rudensky and
colleagues recently showed that Foxp3
programs Treg cell function through the
‘‘exploitation’’ of DNase hypersensitive
sites (DHSs), hot spots of permissive
epigenetic control, identified by DNase-
Seq (Samstein et al., 2012). A comparison
of Foxp3 ChIP-Seq and DNase-Seq data
sets revealed that Foxp3 almost exclu-Elsevier Inc.sively binds DHSs. Furthermore, early in
development, other Foxp3 cofactors,
including Foxo1, can act as surrogates
by binding DHSs until Foxp3 is induced.
Importantly, they also identified TCR
signaling as a crucial factor for the modu-
lation of DHSs, consistent with the obser-
vations of Ohkura et al. in this issue. The
contribution of transcriptional networks
in establishing the signature and stability
of Treg cells has also been explored.
Benoist and colleagues recently pro-
posed that Treg cell identity is pro-
grammed by a genetic switch that uses
multiple redundant transcription factors
to maintain lineage commitment (Fu
et al., 2012). By deriving computational
networks from multiple transcriptome
profiles, they showed that Ikzf2 (encoding
Helios), Xbp1, Ikzf4, Satb1, Lef1, Gata1,
and Irf4 contribute substantially to the
maintenance of Treg cell identity and
stability. Surprisingly, the latter four genes
were redundant: each acted in concert
with Foxp3 to program Treg cell signature
genes and lineage commitment. The
concept that Foxp3 does not act in isola-
tion has also been supported by a recent
study that highlighted an extensive
protein interactome engaged by Foxp3
(Rudra et al., 2012). This network of
more than 300 proteins revealed how indi-
vidual binding partners in this massive
network can be utilized to influence major
changes in Treg function.
The observations of Ohkura et al., in
conjunction with a growing number of
recent studies, are building toward a
consensus that illustrates how several
external stimuli impinge on Foxp3 to
shape the Treg cell epigenetic and tran-
scriptional landscape in order to ensure
their stability and function. Importantly, it
is now clear that Foxp3 is required, but
not sufficient, for the establishment of
a robust and stable Treg cell program.
Foxp3 has been used by many investiga-
tors as the sole marker for Treg cells,
which has led to some conflicting obser-
vations regarding lineage commitment
and stability in vivo. Ohkura et al., have
described the nTreg-Me signature that
defines a more highly committed and
suppressive Treg cell population. Im-
portantly, hypomethylation was Foxp3
independent and appeared to require
strong and/or chronic TCR signaling, sug-
gesting that the definition of a ‘‘natural
Treg’’ requires more than simply Foxp3
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Previewsexpression (Figure 1). However, what
remains unclear is how chronic or strong
TCR signaling causes the demethylation
of such a specific set of genes. Is a certain
threshold of TCR-signal strength or dura-
tion sufficient for inducing demethylation?
Are all the players downstream of the
TCR, or do other cell-extrinsic signals
contribute? Given that chronic in vitro
stimulation could not fully induce nTreg
cell demethylation, the authors suggest
that additional signals might be required
for demethylation of the Foxp3 locus.
Given the importance of IL-2 and TGF-b
in Treg cell function, it would be impor-
tant to interrogate the roles of these
cytokines and other signals in mediating
nTreg-Me. Furthermore, the developmentof novel biomarkers and/or noninvasive
approaches to visualizing nTreg-Me is
critical for further mechanistic dissection
and clinical application.REFERENCES
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The Wnt-responsive transcription factors Tcf1 and Lef1 are well-known for their roles in lymphocyte devel-
opment. In this issue of Immunity, Yu et al. (2012) report that Tcf1-deficient mice develop aggressive T cell
lymphomas that are characterized by high Lef1 expression.A large body of evidence has shown that
canonical Wnt signaling is essential for
thymocyte proliferation and T cell devel-
opment (reviewed in Staal et al. [2008]).
The nuclear response to Wnt signaling
is mediated via a family of four transcrip-
tion factors, Tcf1, Lef1, Tcf3, and Tcf4,
that utilize their HMG (high-mobility-
group) box for sequence-specific DNA
binding. In blood and immune cells,
Tcf1 (T cell factor 1) and Lef1 (lympho-
cyte enhancer-binding factor 1) are
most abundantly expressed. Wnt pro-
teins function during development in
cell fate decisions. In adult life, they
regulate self-renewal of various types
of stem cells, including hematopoietic
stem cells (Clevers, 2006; Luis et al.,
2012). At least three different Wnt path-ways are currently recognized: the
canonical Wnt pathway, which is medi-
ated via b-catenin and Tcf and/or Lef
factors, the planar cell polarity (PCP)
pathway, and the Wnt-Ca2+ pathway
(Staal et al., 2008). In the canonical Wnt
pathway, Wnt proteins bind to their
receptors, thereby preventing proteoso-
mal degradation of the Wnt mediator
b-catenin. Subsequently, b-catenin is
translocated to the nucleus where it
forms an active transcription complex
with the downstream effectors of the
Tcf family. Tcf1 and Lef1 are highly
similar in structure and amino acid
sequence. Both occur as long isoforms
containing a b-catenin-interaction do-
main as well as short isoforms that lack
this domain and function as naturalrepressors of Wnt signaling. The long
isoforms can also function as tran-
scriptional repressors in the absence of
b-catenin when these domains are occu-
pied by Groucho corepressor proteins.
The first reports on Wnt signaling in the
immune system were foreshadowed by
‘‘old’’ experiments demonstrating defects
in T- and B-cell development in mice
deficient for Tcf1 and Lef1, respectively
(reviewed in Staal et al. [2008]). Young
Tcf1-deficient mice display an incomplete
block at the double negative-1 (DN1),
DN2 and immature single positive (SP)
stages of thymocyte development,
whereas older mice have a complete
block at the DN1 stage (see Figure 1,
top, for a description of developmental
stages in the mouse thymus and howovember 16, 2012 ª2012 Elsevier Inc. 761
